Mirikizumab, Mirikizumab clinical trials

I6T-MC-AMBZ - A Multicenter, Phase 3b, Open-Label, Single-Arm Study to Investigate Bowel Urgency and Its Relationship With Other Outcome Measures in Adults With Moderately to Severely Active Ulcerative Colitis Treated With Mirikizumab

This study looks at a new medicine called mirikizumab for adults with a bowel condition called ulcerative colitis. It specifically checks if the medicine helps reduce how often people feel an urgent need to go to the toilet over 12 weeks.